Proscia Secures $46M for Mainstream AI Pathology Platform
AI Chat: ChatGPT, AI News, Artificial Intelligence, OpenAI, Machine Learning
00:00
Elevating AI-Driven Pathology with $46M Funding Round
Prossiza secures $46 million in series C funding to advance their AI-driven pathology software platform, targeting pathology studies, vaccine development, and disease analysis. The funding, including $9 million recently raised, will enhance their presence in the US diagnostic market and support the development of AI applications for life sciences and diagnostic labs.
Play episode from 00:00
Transcript
